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Presidential addresses are often avoided at
meetings and seldom read after publication even
when given by men with much grayer hair than
mine! I was elected President of this distinguished
Society while I was in England on a fellowship
last year and I could not therefore at the time pro-
test my youth and my ineptitude for such respon-
sibility.
My topic might be called integration and the
color problem. I refer to the integration of der-
matology and medicine. And the color problem of
which I shall speak is better stated as the problem
of color. What I mean to convey is that my inter-
est in the problem of color aided appreciably in
integrating the department of dermatology in a
large general hospital and medical school to which
I have recently moved. Let me explain further.
Shortly after I moved to my new position last
fall, I was invited to speak on melanin by the
Medical Service (a clinical discussion of various
melanin pigmentations), by the Metabolic Unit
on the tyrosine-melanin metabolic pathway, by
the Department of Ophthalmology on melanin
pigment in the eye, etc. Having spent the past
fourteen years on the problem of melanin, I was
able to present the results of some original inves-
tigation, and a panoramic view of a subject of
interest to physicians in diverse specialties and to
biologists and biochemists. These meetings re-
sulted in new inter-departmental projects and a
rapprochement of the Department of Dermatol-
ogy and the Hospital and Medical School.
This rather egotistical introduction brings me
to what should have been my topic sentence: The
barriers of the various specialties are collapsing
and although special clinical interests and prob-
lems still exist, we are all engaged in a vast com-
mon enterprise, namely the study of biology. To
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solve the problems of biology in so far as they con-
cern Man, workers in the various segregated areas
are beginning to be interested in the same basic
concepts and to use the same or very similar re-
search methods. Some of the papers recently
given at the Federation Meetings in Chicago or
the American Society for Clinical Investigation,
could have been given here with the same impact
or vice versa.
The future of dermatology in the medical
school is intimately linked with the quality of re-
search. In a decade the question of integration of
dermatology will not be discussed if we continue
to expand the scope and increase the quality of
basic research. I must hasten to add that the
Dermatology Department must, however, not
only match the standard of the other specialties
in research, but must provide also the same excel-
lence in patient care and teaching of the specialty.
To achieve a balance of the triad of patient care,
teaching and research we need to develop indi-
viduals with imaginative leadership and critical
judgment; we need to provide them with oppor-
tunity for training and experience in clinical der-
matology, and a two-year service "at the bench"
in a basic science laboratory. In other words, the
future of dermatology depends on individuals. As
Emerson has so aptly put it "an institution is the
lengthened shadow of a man". Competition for
space and for research funds is becoming increas-
ingly fierce, but the simple truth is that space and
funds follow a good man like a shadow. Let me
give you an illustration. If you ask a medical
student, an intern, or a Professor of Biochemistry
from the University of Chicago Medical School
for his view of the specialty of Dermatology he
will describe the superb and stimulating teaching,
and the high caliber of research. To them the spe-
cialty of Dermatology is represented by men with
critical judgment, teachers who integrate basic
science and clinical problems, individuals who are
making an honest effort to understand normal
and diseased skin with the most recent research
and clinical tools. Compare this with the opinion
of interns from certain of our other excellent mcdi-
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cal schools. They will state that to them dermatol-
ogy represents an esoteric field in which instruc-
tion was given by residents whose presentation
aroused little interest and in which research
seemed to consist in the evaluation of "salves" or
in the nuances of rarely encountered cutaneous
disorders such as acrodermatitis chronica atro-
phicans. For these unfortunates, dermatology has
been segregated from the rest of medicine as a
waif undeserving of serious scientific recognition.
Turning to the more scientific aspects of the
color problem, I would like to point out the inte-
grative possibilities inherent in biochemical ge-
netics. This subject is of interest to dermatologists
and also to investigators in various other fields of
medicine. This is an approach to disease which
relates the clinical and laboratory findings to
altered metabolism. Thus we speak of "biochem-
ical lesions." This concept of disease places it at
the molecular level and the biochemical lesion
may then be the consequence of a gene defect, or
possibly the alteration of the gene by environ-
mental factors (radiation, infections, stress, im-
mune and auto-immune responses). These gene
mutations then bring about the formation of
altered protein molecules including altered en-
zymes. When the gene is altered a new protein is
made which may or may not be functionally de-
fective with different physical properties or de-
creased or absent enzymatic activities. These ab-
normal enzyme proteins lead to blocks in the
normal metabolic pathway.
Today I would like to consider briefly as a
prototype the genetic condition known as albin-
ism. Some of you may consider that this is a rather
unimaginative subject to discuss on this occasion,
but atopie dermatitis and psoriasis, two heredi-
tary dermatoses, will in my opinion ultimately
prove to be gene defects with resulting abnormal
biochemical consequences.
Albinism is an example of one type of metabolic
block in which the enzymatic defect leads to a
deficiency of the product, melanin. I will also
mention later a disease with a different type of
metabolic block, phenylketonuria. In phenylke-
tonuria, decrease in melanin results, not from a
defect of the melanin forming enzyme, tyrosinase,
but from the reversible inhibition of this enzyme
by the enormously increased amounts of phenyl-
alanine in the serum and extracellular fluids.
I have for some time been especially interested
in albinism as evidence of a relationship between
the genes and biochemical lesions. Let me define
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albinism, for present purposes, as an hereditary
(Table I) and congenital deficiency of melanin
caused by a characteristic defect of metabolism
in the melanocyte.
You are probably all aware that albinism oc-
curs throughout the animal kingdom. It may be
seen in vertebrates ranging from brook trout to
whales and man. The incidence in man is reported
to be one in twenty-five thousand. Noah, the
Noah who embarked in the Ark, was an albino,
and so also W. A. Spooner that famous Warden
of New College, Oxford, for whom are named
Spoonerisms, those accidental transpositions of
the initial letters of words. Were he here today he
might tell you that many of my experimental
data have been obtained from the tissues of
pickens and chigs. It was in 1660, after seeing
Negroes with white skin on the African coast,
that Balthazar Tellez, a Portuguese, using the
Latin adjective, albus, coined the Portuguese
term, albino. The condition has been the subject
of speculation for centuries. For many years, al-
binos were considered to stand between apes and
man in the evolutionary scale. Linnaeus, the
Swedish naturalist, grouped them with the cave
dwellers known as Troglodytes, and certain Cen-
tral American Indians even today consider that
albinos are set apart from normal man as being
more intelligent, freer from sin and altogether
nearer to God.
TYPES OF ALBINISM
The metabolic defect of the melanocyte in al-
binism may be present throughout the entire
melanocyte system (Fig. 1) or be limited to the
TABLE I
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Fig. 1. The human melanocyte system
melanocytes of one region of the body. In the
past, clinical nomenclature has not been such that
one could easily specify with clarity either the
extent or the site of involvement. For my own
use, therefore, I have come to employ a more
functional system of terminology which seems to
me to have many advantages over the traditional
system. I present it here for what it may be worth
(Table 1). The term "oculo-cutaneous albinism"
indicates succinctly the simultaneous existence of
the two major visible manifestations of albinotic
abnormality of the melanocyte system and gives
proper emphasis to ocular involvement which is
an inherent part of the syndrome. The term
"ocular albinism," as I use it and as it has been
used in the past, adequately describes the condi-
tion to which it is applied. "Localized cutaneous
albinism" is the term I have come to employ
when the pigmentary deficiency appears only in
localized areas of the skin.
The major clinical features of human albinism
are summarized in Table II. Ocular changes (hy-
popigmented fundus oculi, translucent irides, and
nystagmus) are the most reliable criteria for the
diagnosis of oeulocutaneous albinism because the
color of the hair, eyes and skin of patients with
this disorder may be indistinguishable from that
of normal blonde Caucasians. Localized cutaneous
albini.sm (LCA) may closely resemble segmental
vitiligo, especially when it appears on one side of
the face. The two diseases may be differentiated,
however, by five distinguishing features:
1. The depigmentation of LCA is present at
birth.
2. Physical trauma of the normal skin usually
evokes depigmentation of the traumatized area in
vitiliginous subjects, but does not do so in pa-
tients with localized cutaneous albinism.
3. LCA is present in the family history of more
than fifty per cent of patients. The family names
Whitlock (Whitelock), Horlock (from hoar), Sil-
verlock, Blaylock and Bianconini (literally
"Whitelock") were given to the original holders
of the name because of the presence of a white
forelock.
4. The depigmented lesions of LCA are usually
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TL1 II
—
CLINICAL FEATURES OF HUMAN ALBINISM —
I. Hypopigmented fundus acull
2. Translucent rides
3.Nyslagmus
4. Diffuse (unpatterned) absence
of normal pigmentation in
skin and hair
( I. Ocular findings same as in oculo-
cutaneous olbinism
2. Culaneous findings within normal
range of pigmentation
( I. Congenital, patterned loss of
melanin on extremities andj ventral thorax] 2. White forelock present in majority
of canes
. 3. No ocular findings
on the abdomen and ventral thorax, whereas
those of vitiligo are characteristically found
around the eyes, in the axillae, over bony promi-
nences and at sites of repeated trauma.
5. A tuft of depigmented hair (the white fore-
lock) is present in the mid-frontal area of the
majority of patients with LCA. The similar de-
pigmentation of hair which may be associated
with vitiigo is almost invariably accompanied by
depigmentation of parts of the skin on the face
and other regions of the body.
NATURE OF THE OHEHICAL LESION OF
ALBINISM
In a monumental study of albinism, Karl
Pearson, the English geneticist, concluded that
the deficiency of melanin characteristic of albin-
ism results from a structural defect or an absence
of melanocytes. His thidings were published in
1911, only a few years after Sir Archibald Garrod,
in his Croonian Lectures, had listed albinism
among "inborn errors of metabolism". The con-
ffict between these two points of view could not
be resolved until modern cytological, bistochemi-
cal and biochemical techniques made it possible
to determine whether melanocytes are present in
the skin, hair and eyes of albinos, and whether
there is evidence of a biochemical lesion in al-
binism.
That melanocytes are present in the skin of
albinos was suspected when it became known that
pigmented melanocytic nevi and non-pigmented
melanomas occur in albinotic skin. Only after the
advent of the electron microscope, however, could
the presence of melanocytes in such skin be un-
equivocally demonstrated. These cells can be
identified by their dendritic processes and by the
presence of numerous ovoid or rod-shaped bodies
which are presumed to be amelanic melanin
granules. No evidence has been found to support
Pearson's interpretation of oculo-cutaneous al-
binism as the consequence of a structural defect
of melanocytes.
Data obtained in biochemical and histochemi-
cal studies of skin from chicken, guinea pig, and
man have proved that albinism is due to a defect
of metabolism. In amelanic granules isolated
from the feather papilae of the albino chick,
tyrosinase activity has not been detectable, but
in melanie granules isolated from the feather
papillae of the black Leghorn chick, it has been
found to be abundant (Fig. 2). Following injec-
tion of radioactively labelled tyrosine into the
yolk sacs of black Leghorn and albino chicks,
significant amounts of radioactivity have been
found in the feathers of the black species, and
virtually none in the albino mutants.
Manometric measurement has revealed that
tyrosinase activity is almost completely absent
from the skin of the albino guinea-pig fetus and
that hydroxylation of tyrosine to dopa does not
take place. It has not been possible with mano-
metric technics to demonstrate that tyrosinase
activity is absent in the skin and hair bulbs of
OCULO—CUTANEOUS
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Fio. 2. Tyrosine-tyrosinase and dopa-tyrosinase
activities of feather germ homogenates obtained
from 10 day old chicks—pH 6.8, 38° C substrate
cone: 1.77 jM tyrosine and dopa
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human albinos. However, with histochemical,
radioautographie technics, utilizing tyrosine-2-C'4
as a substrate, tyrosinase activity has not been
found in the melanocytes of the hair bulb of the
human albino.
Failure of melanin to form in albino melano-
cytes from melanogenic substrates (tyrosine and
dopa) could be the result of a lack in the melano-
cyte of genes for 1) tyrosinase synthesis, 2) syn-
thesis of the protein matrix (melanosome), or 3)
polymerization of the monomer, indole-5, 6-qui-
none, to the melanin polymer. Viewed under the
electron microscope, the amelanic melanosomes
(melanin granules) of the human albino hair bulb
appear to be exactly like the melanie melanosomes
present in the normal pigmented hair bulb. It
would seem therefore that the defect in albinism
must be either a failure of tyrosinase synthesis or
of melanin polymerization. The latter possibility
is unlikely, since there is no hydroxylation by ho-
mogenates of the fetal skin of albino guinea pigs.
If the defect in albiism were a failure of melanin
polymerization, then hydroxylation of tyrosine
would be required to provide the precursor, dopa,
which ultimately leads to the formation of indole-
5, 6-quinone, the monomer that polymerizes to
melanin. All available evidence indicates, there-
fore, that the biochemical lesion of albinism re-
sults from absence in the melanocyte of the gene
which is required for the synthesis of tyrosinase.
EFFECT ON TYROSINE METABOLISM OF A "BLOCK"
IN THE TYROSINE-MELANJN PATHWAY
One might expect that the marked decrease or
absence of tyrosinase in the melanocytes of al-
binos would act as a metabolic "block" behind
which tyrosine would accumulate as do phenylal-
amine and related metabolites in the extra-cellular
fluids of patients with phenylketonuria when L-
phenylalanine oxidase is absent from the liver or
present only in reduced amounts. We have not
been able to obtain biochemical evidence that
there is such an accumulation of tyrosine in al-
binism. No decrease in the urinary excretion of
adrenalin and nor-adrenalin was observed in six
albino patients and study of serum protein-bound
iodine and I's' uptake in human albinos suggests
that the other major pathway of tyrosine, to thy-
roxin, is unchanged in these subjects. It would
appear therefore that the albino can metabolize
tyrosine which may accumulate as the result of a
block in the tyrosine-melanin pathway. In phe-
nylketonuria, by way of contrast, the characteris-
tic decrease in melanin results not from a defect
of the melanin-forming enzyme, tyrosinase, but
from the reversible inhibition of this enzyme, by
enormous amounts of phenylalanine which ac-
cumulate in the serum and extracellular fluids.
Phenylalanine and its degradation products act
as competitive inhibitors not only of tyrosinase,
with resulting decrease in melanin formation, but
also of adrenalin formation, as evidenced by de-
creased excretion of adrenalin and nor-adrenalin
in the urine.
It has been stated previously that two types of
evidence are required for conclusive proof of the
existence of a specific enzymatic deficiency in any
given metabolic disorder: 1) in vitro demonstra-
tion of a decrease or absence of the enzyme which
is known not to result from the effect of inhibi-
tors; and, 2) in vivo demonstration of biochemical
changes in body fluids or tissues and of changes
in metabolism, under experimental conditions,
which can be attributed to the diminution or ab-
sence of a reaction which is normally catalyzed
by the enzyme in question. The biochemical and
histochemical studies I have just outlined appear
to satisfy the first requirement: i.e., tyrosinase is
lacking in the melanocyte of the albino. Existing
data do not, however, entirely satisfy the second
requirement, although absence of melanin in
albinotic skin is proof that the block of the ty-
rosine-melanin pathway is attributable to the
absence of tyrosinase.
I have attempted to sketch with the broadest
strokes the genetic condition known as albinism
and to emphasize its significance as the prototype
of a disorder in which the clinical findings can be
related to a biochemical lesion. Similar informa-
tion is needed on some of the more important and
disabling cutaneous disorders such as atopic der-
matitis and psoriasis.
We are living in an era in which the expansion
of scientific knowledge has already assumed astro-
nomical proportions. Each successive discovery
seems to lead the way to still further discoveries
and to draw increasing numbers of investigators
into the field of research. Technics of investiga-
tion are now available which surpass in accuracy
and ingenuity anything previously conceived of.
Like all other sub-specialties of medicine, derma-
tology has been caught up in this movement.
Dermatologists are being challenged to think in
terms of the most advanced scientific knowledge.
To meet this challenge we must be able to inte-
grate basic science with clinical skill and to train
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students to do likewise. Nosology is no longer
sufficient. In much of our past research effort
there has been too much fervor and too little
measure. This does not mean that we should re-
treat to the laboratory and substitute the bench
for the bed. It means, rather, that we must main-
tain an even balance of the triad of patient care,
teaching, and research. We cannot meet the chal-
lenge without insisting upon the highest possible
standards of work and developing a tradition of
excellence.
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